FI68174C - Foerfarande foer framstaellning av cyklodextrin-kamomill-inklusionskomplex foer farmaceutiskt bruk - Google Patents
Foerfarande foer framstaellning av cyklodextrin-kamomill-inklusionskomplex foer farmaceutiskt bruk Download PDFInfo
- Publication number
- FI68174C FI68174C FI793504A FI793504A FI68174C FI 68174 C FI68174 C FI 68174C FI 793504 A FI793504 A FI 793504A FI 793504 A FI793504 A FI 793504A FI 68174 C FI68174 C FI 68174C
- Authority
- FI
- Finland
- Prior art keywords
- chamomile
- cyclodextrin
- complex
- oil
- process according
- Prior art date
Links
- 240000003538 Chamaemelum nobile Species 0.000 claims description 42
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- 229940119217 chamomile extract Drugs 0.000 claims description 6
- 235000020221 chamomile extract Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 229940070641 chamomile flowers Drugs 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 239000010630 cinnamon oil Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 238000001035 drying Methods 0.000 claims 2
- 239000003208 petroleum Substances 0.000 claims 2
- 238000010668 complexation reaction Methods 0.000 claims 1
- 238000001256 steam distillation Methods 0.000 claims 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 36
- 229920000858 Cyclodextrin Polymers 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000010628 chamomile oil Substances 0.000 description 17
- 235000019480 chamomile oil Nutrition 0.000 description 17
- 239000004480 active ingredient Substances 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 230000037396 body weight Effects 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000001116 FEMA 4028 Substances 0.000 description 8
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 229960004853 betadex Drugs 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 6
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000021053 average weight gain Nutrition 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 230000008033 biological extinction Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000020346 chamomile tea Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RKBAYVATPNYHLW-IPYPFGDCSA-N 2-[(2S,5S)-5-methyl-5-[(1S)-4-methylcyclohex-3-en-1-yl]oxolan-2-yl]propan-2-ol Chemical compound OC(C)(C)[C@H]1O[C@](C)([C@@H]2CC=C(C)CC2)CC1 RKBAYVATPNYHLW-IPYPFGDCSA-N 0.000 description 2
- WJHRAVIQWFQMKF-IPYPFGDCSA-N Bisabolol oxide A Chemical compound C1CC(C)=CC[C@H]1[C@@]1(C)OC(C)(C)[C@@H](O)CC1 WJHRAVIQWFQMKF-IPYPFGDCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000001539 phagocyte Anatomy 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 206010050247 Anal inflammation Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000074881 Conyza canadensis Species 0.000 description 1
- 235000004385 Conyza canadensis Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000007239 Heracleum sphondylium Nutrition 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000001043 capillary endothelial cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N dimethylsulfide Substances CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000501 effect on contamination Effects 0.000 description 1
- 230000000797 effect on infection Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000010334 sieve classification Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- WHGYBXFWUBPSRW-FEYSZYNQSA-N β-dextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)C(O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FEYSZYNQSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI001867 | 1978-11-20 | ||
| HU78CI1867A HU176217B (en) | 1978-11-20 | 1978-11-20 | Process for preparing a cyclodextrin-chamomille inclusion complex and compositions containing thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI793504A7 FI793504A7 (fi) | 1980-05-21 |
| FI68174B FI68174B (fi) | 1985-04-30 |
| FI68174C true FI68174C (fi) | 1985-08-12 |
Family
ID=10994713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI793504A FI68174C (fi) | 1978-11-20 | 1979-11-08 | Foerfarande foer framstaellning av cyklodextrin-kamomill-inklusionskomplex foer farmaceutiskt bruk |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5573617A (de) |
| AT (1) | AT363176B (de) |
| BE (1) | BE880155A (de) |
| CH (1) | CH647534A5 (de) |
| CS (1) | CS223972B2 (de) |
| DD (1) | DD146893A1 (de) |
| DE (1) | DE2944350A1 (de) |
| DK (1) | DK491679A (de) |
| ES (1) | ES486109A1 (de) |
| FI (1) | FI68174C (de) |
| FR (1) | FR2441389A1 (de) |
| GB (1) | GB2037306B (de) |
| HU (1) | HU176217B (de) |
| IT (1) | IT1119944B (de) |
| NL (1) | NL7908354A (de) |
| NO (1) | NO155625C (de) |
| PL (1) | PL126984B1 (de) |
| SE (1) | SE7909505L (de) |
| SU (1) | SU1514240A3 (de) |
| YU (1) | YU280379A (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU184066B (en) | 1979-12-28 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Plant growth regulating substance and process for preparing such compound |
| JPS5724306A (en) * | 1980-07-16 | 1982-02-08 | Wakunaga Yakuhin Kk | Preparation of solid chinese herbal pharmaceutical |
| HU181733B (en) | 1980-08-07 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing sorbents containing cyclodextrin on cellulose base |
| HU180183B (en) * | 1980-12-19 | 1983-02-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing stable suppository compositions containing volatile and/or labile active substances |
| JPS5830032B2 (ja) * | 1981-02-18 | 1983-06-27 | 呉羽化学工業株式会社 | ビフイダス菌の増殖剤 |
| JPS5813541A (ja) | 1981-07-16 | 1983-01-26 | Kureha Chem Ind Co Ltd | エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物 |
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| GB2179551A (en) * | 1984-09-01 | 1987-03-11 | Jeanette Hill | Hair treatment preparations |
| FR2578422B1 (fr) * | 1985-03-05 | 1987-06-26 | Cariel Leon | Composition de traitement a usage topique externe a base de luteoline et procede de preparation |
| HU196306B (en) * | 1985-04-01 | 1988-11-28 | Chinoin Gyogyszer Es Vegyeszet | New dusting powders comprising bioactive material and process for preparing the same |
| US4678598A (en) * | 1985-08-06 | 1987-07-07 | Kao Corporation | Liquid shampoo composition |
| JP2703083B2 (ja) * | 1989-04-28 | 1998-01-26 | アレクサンドル ミハイロビチ デリアビン | 動物およびヒトにおける乳腺炎の治療用医薬 |
| DE4338508A1 (de) * | 1993-11-11 | 1995-05-18 | Asta Medica Ag | Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten |
| CA2211222A1 (en) * | 1996-09-04 | 1998-03-04 | Warner-Lambert Company | Shaving aid with complexing agent |
| DE19746284A1 (de) * | 1997-10-20 | 1999-04-22 | Robugen Gmbh | Kosmetische und pharmazeutische Mittel auf Basis eines Kamillenextraktes |
| RU2192140C2 (ru) * | 2000-08-15 | 2002-11-10 | Белецкая Ирина Глебовна | Способ приготовления чайного продукта |
| ES2171147B1 (es) * | 2001-02-06 | 2003-12-16 | Esteve Labor Dr | Preparacion para usos veterinarios. |
| WO2004035071A1 (en) * | 2002-10-17 | 2004-04-29 | Nakar, Herzl | Herbal medicine containing cyclodextrins for the treatment of ear disorders |
| FR2898817B1 (fr) * | 2006-03-23 | 2008-08-08 | Univ Rouen | Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines |
| JP2009091309A (ja) * | 2007-10-10 | 2009-04-30 | Japan Organo Co Ltd | バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品 |
| CN114533896B (zh) * | 2020-11-26 | 2024-05-31 | 江西济民可信集团有限公司 | 一种包合物及其制备方法、应用、含其的金芩花颗粒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5443570B2 (de) * | 1972-10-27 | 1979-12-20 | ||
| JPS5423966B2 (de) * | 1972-11-11 | 1979-08-17 | ||
| JPS5017529B2 (de) * | 1972-11-20 | 1975-06-21 | ||
| JPS53126089A (en) * | 1977-04-11 | 1978-11-02 | Akiyama Jiyouzai Kk | Cyclodextrin clathrate compound including safflower oil |
| HU174699B (hu) * | 1977-07-01 | 1980-03-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija natural'nykh i sinteticheskikh ciklodektrinnykh okkluzionnykh kompleksov prjaznostej, aromatov i vkusnykh vehhestv |
-
1978
- 1978-11-20 HU HU78CI1867A patent/HU176217B/hu unknown
-
1979
- 1979-11-02 DE DE19792944350 patent/DE2944350A1/de not_active Ceased
- 1979-11-08 GB GB7938763A patent/GB2037306B/en not_active Expired
- 1979-11-08 FI FI793504A patent/FI68174C/fi not_active IP Right Cessation
- 1979-11-12 CS CS797712A patent/CS223972B2/cs unknown
- 1979-11-15 YU YU02803/79A patent/YU280379A/xx unknown
- 1979-11-15 NL NL7908354A patent/NL7908354A/nl not_active Application Discontinuation
- 1979-11-16 FR FR7928299A patent/FR2441389A1/fr active Granted
- 1979-11-16 SE SE7909505A patent/SE7909505L/xx unknown
- 1979-11-16 IT IT69222/79A patent/IT1119944B/it active
- 1979-11-19 ES ES486109A patent/ES486109A1/es not_active Expired
- 1979-11-19 DK DK491679A patent/DK491679A/da not_active Application Discontinuation
- 1979-11-19 NO NO793731A patent/NO155625C/no unknown
- 1979-11-19 SU SU792849102A patent/SU1514240A3/ru active
- 1979-11-19 DD DD79216972A patent/DD146893A1/de not_active IP Right Cessation
- 1979-11-19 CH CH10311/79A patent/CH647534A5/de not_active IP Right Cessation
- 1979-11-19 JP JP14992679A patent/JPS5573617A/ja active Pending
- 1979-11-20 PL PL1979219739A patent/PL126984B1/pl unknown
- 1979-11-20 BE BE0/198200A patent/BE880155A/fr not_active IP Right Cessation
- 1979-11-20 AT AT0738579A patent/AT363176B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT1119944B (it) | 1986-03-19 |
| JPS5573617A (en) | 1980-06-03 |
| BE880155A (fr) | 1980-03-17 |
| DK491679A (da) | 1980-05-21 |
| CS223972B2 (en) | 1983-11-25 |
| PL219739A1 (de) | 1980-12-01 |
| NO155625B (no) | 1987-01-19 |
| NO793731L (no) | 1980-05-21 |
| AT363176B (de) | 1981-07-10 |
| YU280379A (en) | 1984-12-31 |
| DD146893A1 (de) | 1981-03-11 |
| PL126984B1 (en) | 1983-09-30 |
| HU176217B (en) | 1981-01-28 |
| SE7909505L (sv) | 1980-05-21 |
| CH647534A5 (de) | 1985-01-31 |
| ATA738579A (de) | 1980-12-15 |
| DE2944350A1 (de) | 1980-05-29 |
| GB2037306B (en) | 1983-06-15 |
| FR2441389A1 (fr) | 1980-06-13 |
| ES486109A1 (es) | 1980-09-01 |
| FI793504A7 (fi) | 1980-05-21 |
| FR2441389B1 (de) | 1984-02-10 |
| IT7969222A0 (it) | 1979-11-16 |
| FI68174B (fi) | 1985-04-30 |
| NO155625C (no) | 1987-04-29 |
| SU1514240A3 (ru) | 1989-10-07 |
| GB2037306A (en) | 1980-07-09 |
| NL7908354A (nl) | 1980-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI68174B (fi) | Foerfarande foer framstaellning av cyklodextrin-kamomill-inklusionskomplex foer farmaceutiskt bruk | |
| CN107213467A (zh) | 一种姜黄素磷脂复合物的制备方法 | |
| US20020136777A1 (en) | Functional antidiabetic drink | |
| CN103800916A (zh) | 水难溶性小分子药物的葡聚糖包合物及其制备方法 | |
| EP2403513A2 (de) | Weizenkeimgärstofffraktionen | |
| CN101011091B (zh) | 发酵茶叶、发酵茶叶提取物、用于抑制血糖值上升的组合物以及饮食品 | |
| FR2633184B1 (fr) | Principe actif isole de l'ecorce de mimosa tenuiflora, sa preparation et son application pharmaceutique | |
| JPH11228441A (ja) | 生体の抗酸化機能増強剤 | |
| Fu et al. | Comprehensive Assessment of the Safety of | |
| KR20150073438A (ko) | 미생물을 이용한 단삼 발효산물을 제조하는 방법 | |
| Atef et al. | Metabolism of sulphadiazine in goats | |
| CN1868520B (zh) | 复方芦荟软胶囊制剂及其制备方法 | |
| CN106943605B (zh) | 奥利司他包合物及其制备方法和在抗肿瘤药物中的应用 | |
| TWI618540B (zh) | Composition for preventing renal toxicity caused by drug toxicity, preparation method thereof and Its use | |
| JP2884098B2 (ja) | クジン由来細胞賦活物質 | |
| CN113244339B (zh) | 一种用于高脂血症的考来烯胺散及其制备方法 | |
| EP0393973A1 (de) | Antikrebsmittel gegen Lungenkrebs | |
| CN111214404A (zh) | 一种茵陈复配型防腐剂及其制备工艺与应用 | |
| RU2181051C1 (ru) | Способ получения инъекционного средства на основе вещества с р-витаминной активностью | |
| JPH06122631A (ja) | 多機能性蛋白質 | |
| CN1951404A (zh) | 银杏叶口服微乳及其制备方法 | |
| WO2006115202A1 (ja) | ニコチンの毒性軽減組成物 | |
| CN120713947A (zh) | 一种微压辅助共晶溶剂的土木香提取物制备及应用 | |
| CN113893214A (zh) | 喙尾琵甲提取物在化妆品中的应用 | |
| RU2423991C2 (ru) | Гепатопротекторное средство, обладающее антиоксидантным действием, и способ его получения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK |